Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

LifeStance Health (LFST) Equity Average (2021 - 2025)

Historic Equity Average for LifeStance Health (LFST) over the last 5 years, with Q3 2025 value amounting to $1.5 billion.

  • LifeStance Health's Equity Average rose 347.18% to $1.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 billion, marking a year-over-year increase of 347.18%. This contributed to the annual value of $1.4 billion for FY2024, which is 245.75% down from last year.
  • According to the latest figures from Q3 2025, LifeStance Health's Equity Average is $1.5 billion, which was up 347.18% from $1.5 billion recorded in Q2 2025.
  • Over the past 5 years, LifeStance Health's Equity Average peaked at $1.5 billion during Q4 2021, and registered a low of $1.4 billion during Q1 2024.
  • Moreover, its 5-year median value for Equity Average was $1.5 billion (2025), whereas its average is $1.5 billion.
  • Its Equity Average has fluctuated over the past 5 years, first tumbled by 548.72% in 2024, then skyrocketed by 347.18% in 2025.
  • Over the past 5 years, LifeStance Health's Equity Average (Quarter) stood at $1.5 billion in 2021, then fell by 1.28% to $1.5 billion in 2022, then dropped by 5.45% to $1.4 billion in 2023, then dropped by 0.02% to $1.4 billion in 2024, then increased by 2.89% to $1.5 billion in 2025.
  • Its Equity Average was $1.5 billion in Q3 2025, compared to $1.5 billion in Q2 2025 and $1.5 billion in Q1 2025.